CMP looks too cheap fundamentally and technically.
Is already profitable and generates very healthy revenues. Is a world leader in the sleep diagnostic market and now has a treatment device to compete with RMD in the field of sleep apnoea.
I think a major re-rating is close and could be sparked by the release of the FY results.
DYOR
CMP looks too cheap fundamentally and technically.Is already...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.005(1.75%) |
Mkt cap ! $55.74M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 29.0¢ | $2.465K | 8.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26600 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 20999 | 1 |
View Market Depth
| Last trade - 11.51am 22/07/2025 (20 minute delay) ? |
| CMP (ASX) Chart |